SAN DIEGO, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in discovery of inhibitors of challenging targets for inflammatory disease and cancer, today announced that Fierce Biotech has named it as one of 2024’s “Fierce 15” biotechnology companie...
Cerevance has been named by Fierce Biotech as one of the most promising early-stage biotechnology companies in the industry in 2023, showcased on this year’s Fierce 15 list. BOSTON, Aug. 28, 2023 (GLOBE NEWSWIRE) --Cerevance, a private, clinical-stage drug discovery and development...
We could be witnessing the beginning of a merger wave in biotech, where smaller firms are acquired by big drug companies looking for a new source of growth, Jim Cramer said Tuesday. Amgen’s$10 billion takeoverofOnyx Pharmaceuticals, in addition toGilead Sciences’ acquisition of Pharmasset two...
HiFiBiO Therapeutics, a clinical stage global biotech company focusing on improving patient lives with single cell precision, announced that Fierce Biotech has named it as one of 2023’s “Fierce 15” biotechnology companies.
Gregg Renfrew, founder of Beautycounter, will take a new role as executive chair and chief brand officer.
And while it’s an arbitrary line, it’s also a signal of how the industry is evolving — both companies are biotechs that have spent years building their R&D identities with a sharper scientific focus and far less dealmaking than typically seen in pharma boardrooms. It’s a sign that ne...
— Biotech company Absci, whichfiled to go public last week, addedNikhil Goelas chief business officer andSarah Kormanas general counsel. Goel was previously an investment banker working with biotech companies. Most recently, he was a director at Credit Suisse working on mergers and acquisitions. ...
These leaders will discuss the impact of pharmeceutical companies' struggles to meet the financial world’s growth expectations for the biotech sector. "Alternative Financing: Unconventional Routes to Capital" -- Led by Ludger Wess, managing partner with Akampion, a network of professionals who ...
“The appointment of Louis to the CEO position at Nars is in recognition of Louis’ achievements at BPI," said Shuichi Tanaka, chairman and CEO, Shiseido International Corp. "I am convinced that with [Desazars's] background and vision he will bring new ideas and energy to Nars to propel...
“Dolores’ diverse biotech experience and therapeutic production expertise will immediately contribute to growing TAAV’s worldwide synthetic DNA manufacturing business,” said Sheila Mikhail, TAAV Board Chair and AskBio Co-Founder and Chief Executive Officer. “The Board values her strategi...